Cannabis ramp-up for Village Farms is going smoothly, Echelon Wealth says

BC-based Village Farms International (Village Farms Stock Quote, Chart, News: TSX:VFF) has its cannabis expansion plans proceeding very smoothly, says Russell Stanley, analyst with Echelon Wealth Partners. In a client update on Monday, Stanley reiterated his “Speculative Buy” rating and 12-month target price of $13.00 for VFF.

Village Farms released its year-end 2017 financial results on Monday, with the results solely reflecting the company’s existing produce business as one of the largest growers of greenhouse tomatoes in North America. But the release included an update on the progress of its Pure Sunfarms 50/50 joint venture with cannabis company Emerald Health Therapeutics (TSXV:EMH).

“Since announcing our entry into the Canadian cannabis industry last June, the Pure Sunfarms joint venture has consistently executed on all facets of its plan, culminating with Health Canada’s issuance of the cultivation license for Pure Sunfarms’ 1.1 million ft. sq. Delta 3 greenhouse earlier this month,” said Michael DeGiglio, CEO of Village Farms in a press release. “Village Farms is always focused on maximizing the return from our assets and with conversion of the first quadrant of the Delta 3 greenhouse nearing completion, Village Farms has modelled and proposed a strategy to significantly and accretively accelerate the production ramp-up plan for Delta 3, which Pure Sunfarms is now pursuing.”

Stanley says the “very smooth” progress on its cannabis ramp-up combined with VFF’s recent share price weakness constitutes a buying opportunity for investors.

“Our estimate revisions are very minor at this point. We continue to assume that the joint venture can finance conversion of the first three quadrants of the Delta 3 facility, though full conversion may be possible,” says the analyst. “Conversion of the first three quadrants implies annualized cultivation capacity of 56,250kg, and our model assumes that VFF operates at a very reasonable 75 per cent of that capacity. That capacity estimate assumes very conservative yields of 68 grams/square foot of facility footprint versus the average amongst comparable greenhouse projects of 94 grams/square foot.”

The analyst says that VFF trades at 6.3x his EV/2019 EBITDA estimate, which is low compared to its closest peers in the sub-$1 billion market cap category at 10.5x and versus the broader peer group adjusted average of 16.3x, thus representing a “steep discount” of 40 per cent and 62 per cent, respectively.

Stanley’s $13.00 target represents a projected return of 155 per cent as of publication date.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: vff
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

2 hours ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

3 hours ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

3 hours ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

18 hours ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

1 day ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

1 day ago